ZA853877B - Dihydropyridine combination preparations and process for their preparation - Google Patents

Dihydropyridine combination preparations and process for their preparation

Info

Publication number
ZA853877B
ZA853877B ZA853877A ZA853877A ZA853877B ZA 853877 B ZA853877 B ZA 853877B ZA 853877 A ZA853877 A ZA 853877A ZA 853877 A ZA853877 A ZA 853877A ZA 853877 B ZA853877 B ZA 853877B
Authority
ZA
South Africa
Prior art keywords
dihydropyridine
preparation
combination preparations
preparations
combination
Prior art date
Application number
ZA853877A
Other languages
English (en)
Inventor
Ulrich Posanski
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA853877B publication Critical patent/ZA853877B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA853877A 1984-05-23 1985-05-22 Dihydropyridine combination preparations and process for their preparation ZA853877B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843419131 DE3419131A1 (de) 1984-05-23 1984-05-23 Dihydropyridinkombinationspraeparate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ZA853877B true ZA853877B (en) 1986-01-29

Family

ID=6236599

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA853877A ZA853877B (en) 1984-05-23 1985-05-22 Dihydropyridine combination preparations and process for their preparation

Country Status (8)

Country Link
EP (1) EP0163984A3 (instruction)
JP (1) JPS60255725A (instruction)
CN (1) CN85101697A (instruction)
AU (1) AU576244B2 (instruction)
DE (1) DE3419131A1 (instruction)
ES (1) ES8607017A1 (instruction)
GR (1) GR851245B (instruction)
ZA (1) ZA853877B (instruction)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3427402A1 (de) * 1984-07-25 1986-01-30 Bayer Ag, 5090 Leverkusen Neues kombinationspraeparat, verfahren zu seiner herstellung und seine verwendung als arzneimittel
DE3447170A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Mischung unterschiedlicher dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
JPS6396126A (ja) * 1986-10-13 1988-04-27 Taisho Pharmaceut Co Ltd 安定化組成物
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
DE3829398A1 (de) * 1988-08-30 1990-03-08 Rentschler Arzneimittel Fixe arzneimittelkombination mit verzoegerter freisetzung
GB8926715D0 (en) * 1989-11-28 1990-01-17 Haessle Ab Improvements relating to the administration of pharmaceutical agents
JPH05221863A (ja) * 1991-08-09 1993-08-31 Taisho Pharmaceut Co Ltd 安定化方法
US7125565B2 (en) * 2000-12-01 2006-10-24 Kyowa Hakko Kogyo Co., Ltd. Composition improved in the solubility or oral absorbability
AU2005278782B2 (en) 2004-07-30 2011-04-21 Torrent Pharmaceuticals Limited Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
CH655658B (instruction) * 1980-09-18 1986-05-15
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
DE3419129A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Nifedipinpraeparate und verfahren zu ihrer herstellung
DE3419128A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Dihydropyridinpraeparate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
CN85101697A (zh) 1987-01-24
JPS60255725A (ja) 1985-12-17
EP0163984A2 (de) 1985-12-11
GR851245B (instruction) 1985-11-25
ES8607017A1 (es) 1986-06-01
DE3419131A1 (de) 1985-11-28
AU4281085A (en) 1985-11-28
EP0163984A3 (de) 1986-03-19
ES543351A0 (es) 1986-06-01
AU576244B2 (en) 1988-08-18

Similar Documents

Publication Publication Date Title
DE3568994D1 (en) Crosslinking agents and process for their preparation
EP0169114A3 (en) Human alpha-1-antitrypin derivatives and process for their preparation
ZA865263B (en) Poly-4-aminopyrrole-2-carboxamido derivatives and process for their preparation
AP8700063A0 (en) Pesticidal compositions and process for preparation thereof
GB2178036B (en) Poly-4-aminopyrrole-2-carboxamido derivatives and process for their preparation
ZA853874B (en) Dihydropyridine preparations and process for their preparation
HUT37932A (en) Process for preparing 4-hydroxy-2h-1-benzo-thiopyrane-2-one-derivatives and for preparing rhodenticide preparations comprising such compounds
EP0159875A3 (en) Polyester and process for preparation thereof
ZA853877B (en) Dihydropyridine combination preparations and process for their preparation
DE3567638D1 (en) 2,4-dichloro-3-alkyl-6-nitrophenols and process for their preparation
DE3560528D1 (en) Novel 2-substituted 3-sulphopropyl-ammoniumbetaines and process for their preparation
GB2167034B (en) Capsules and process for their preparation
ZA853875B (en) Nifedipine preparations and process for their preparation
ZA861619B (en) Glycoside and process for preparation thereof
ZA853878B (en) Nifedipine combination preparations and process for their preparation
EP0263309A3 (en) Bromofluoroethylhypofluorite and process for its preparation
DE3560791D1 (en) Menadioncholine-bisulfite adduct and process for its preparation
DE3662097D1 (en) 4-mercaptobenzonitriles and process for their preparation
DE3661635D1 (en) Ketosultams and process for their preparation
BG47569A1 (en) 1- thiocarbamoylmethylpyrolidene- 2- tion and method for its preparation
GB2161801B (en) N-imidazolyl derivatives and process for their preparation
EP0232536A3 (en) Spirodiphosphoamidate type compounds and process for their preparation
IL75224A0 (en) Tetrahydronaphthalenols and process for the preparation thereof
ZA865554B (en) Antiparasitc agents and process for their preparation
BG48273A1 (en) Polymerisationable oligoimide and method for its preparation